Connective Tissue Growth Factor (CCN Family Member 2 or Hypertrophic Chondrocyte Specific Protein 24 or Insulin Like Growth Factor Binding Protein 8 or IGFBP8 or CTGF) - Pipeline Review, H2 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Connective Tissue Growth Factor (CCN Family Member 2 or Hypertrophic Chondrocyte Specific Protein 24 or Insulin Like Growth Factor Binding Protein 8 or IGFBP8 or CTGF) - Pipeline Review, H2 2016" drug pipelines to their offering.

This report provides comprehensive information on the therapeutic development for Connective Tissue Growth Factor, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Connective Tissue Growth Factor and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Mentioned:

  • FibroGen, Inc.
  • ProMetic Life Sciences Inc.
  • RXi Pharmaceuticals Corporation

Key Topics Covered:

  • Introduction
  • Connective Tissue Growth Factor Overview
  • Therapeutics Development
  • Pipeline Products for Connective Tissue Growth Factor - Overview
  • Pipeline Products for Connective Tissue Growth Factor - Comparative Analysis
  • Connective Tissue Growth Factor - Therapeutics under Development by Companies
  • Connective Tissue Growth Factor - Therapeutics under Investigation by Universities/Institutes
  • Connective Tissue Growth Factor - Pipeline Products Glance
  • Late Stage Products
  • Clinical Stage Products
  • Early Stage Products
  • Connective Tissue Growth Factor - Products under Development by Companies
  • Connective Tissue Growth Factor - Products under Investigation by Universities/Institutes
  • Connective Tissue Growth Factor - Companies Involved in Therapeutics Development

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/k24vxh/connective_tissue

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Immune Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Immune Disorders Drugs